Cullen/Frost Bankers, Inc. Baxter International Inc Transaction History

Cullen/Frost Bankers, Inc.

$7.23 Billion
Q3 2024

A detailed history of Cullen/Frost Bankers, Inc. transactions in Baxter International Inc stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 113,274 shares of BAX stock, worth $3.34 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

113,274

Previous 116,578 2.83%

Holding current value

$3.34 Million

Previous $3.9 Million 10.31%

% of portfolio

0.06%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$32.85 - $40.26 $108,536 - $133,019	-3,304 Reduced 2.83%	113,274 $4.3 Million
Q2 2024 Aug 05, 2024	BUY	$32.87 - $43.55 $65,411 - $86,664	1,990 Added 1.74%	116,578 $3.9 Million
Q1 2024 May 10, 2024	BUY	$37.88 - $43.77 $1.24 Million - $1.43 Million	32,717 Added 39.96%	114,588 $4.9 Million
Q4 2023 Feb 06, 2024	SELL	$31.71 - $38.95 $1.1 Million - $1.35 Million	-34,766 Reduced 29.81%	81,871 $3.17 Million
Q3 2023 Nov 02, 2023	BUY	$37.32 - $49.29 $87,925 - $116,127	2,356 Added 2.06%	116,637 $4.4 Million
Q2 2023 Aug 04, 2023	SELL	$39.98 - $47.68 $4,717 - $5,626	-118 Reduced 0.1%	114,281 $5.21 Million
Q1 2023 May 05, 2023	BUY	$37.58 - $52.57 $220,143 - $307,955	5,858 Added 5.4%	114,399 $4.64 Million
Q4 2022 Feb 13, 2023	BUY	$49.7 - $57.71 $2.21 Million - $2.57 Million	44,554 Added 69.63%	108,541 $5.53 Million
Q3 2022 Nov 07, 2022	BUY	$53.86 - $66.8 $454,470 - $563,658	8,438 Added 15.19%	63,987 $3.45 Million
Q2 2022 Aug 05, 2022	SELL	$63.83 - $80.0 $41,425 - $51,920	-649 Reduced 1.15%	55,549 $3.57 Million
Q1 2022 May 09, 2022	BUY	$76.85 - $89.45 $389,168 - $452,974	5,064 Added 9.9%	56,198 $4.36 Million
Q4 2021 Feb 07, 2022	SELL	$74.57 - $87.19 $195,746 - $228,873	-2,625 Reduced 4.88%	51,134 $4.39 Million
Q3 2021 Nov 04, 2021	BUY	$73.77 - $83.61 $192,687 - $218,389	2,612 Added 5.11%	53,759 $4.32 Million
Q2 2021 Aug 05, 2021	BUY	$80.5 - $88.01 $28,094 - $30,715	349 Added 0.69%	51,147 $4.12 Million
Q1 2021 May 05, 2021	BUY	$76.38 - $86.03 $737,983 - $831,221	9,662 Added 23.49%	50,798 $4.28 Million
Q4 2020 Feb 08, 2021	BUY	$75.39 - $82.36 $108,863 - $118,927	1,444 Added 3.64%	41,136 $3.3 Million
Q3 2020 Nov 05, 2020	BUY	$78.33 - $90.73 $2.18 Million - $2.53 Million	27,867 Added 235.66%	39,692 $3.19 Million
Q2 2020 Aug 05, 2020	BUY	$78.66 - $94.14 $1,179 - $1,412	15 Added 0.13%	11,825 $1.02 Million
Q1 2020 May 01, 2020	SELL	$71.57 - $93.3 $2,648 - $3,452	-37 Reduced 0.31%	11,810 $959,000
Q4 2019 Feb 06, 2020	SELL	$76.7 - $88.45 $53,690 - $61,915	-700 Reduced 5.58%	11,847 $991,000
Q3 2019 Nov 01, 2019	SELL	$81.4 - $89.78 $45,746 - $50,456	-562 Reduced 4.29%	12,547 $1.1 Million
Q2 2019 Aug 01, 2019	SELL	$73.44 - $82.41 $52,509 - $58,923	-715 Reduced 5.17%	13,109 $1.07 Million
Q1 2019 Apr 30, 2019	SELL	$64.48 - $81.31 $200,210 - $252,467	-3,105 Reduced 18.34%	13,824 $1.12 Million
Q4 2018 Feb 06, 2019	SELL	$61.45 - $77.8 $78,225 - $99,039	-1,273 Reduced 6.99%	16,929 $1.11 Million
Q3 2018 Oct 29, 2018	SELL	$70.71 - $77.75 $56,073 - $61,655	-793 Reduced 4.17%	18,202 $1.4 Million
Q2 2018 Jul 27, 2018	SELL	$63.43 - $75.41 $53,978 - $64,173	-851 Reduced 4.29%	18,995 $1.4 Million
Q1 2018 May 11, 2018	SELL	$62.56 - $72.26 $231,534 - $267,434	-3,701 Reduced 15.72%	19,846 $1.29 Million
Q4 2017 Jan 31, 2018	SELL	$61.45 - $66.05 $28,144 - $30,250	-458 Reduced 1.91%	23,547 $1.52 Million
Q3 2017 Nov 02, 2017	BUY	$59.5 - $64.61 $1.43 Million - $1.55 Million	24,005	24,005 $1.51 Million

Others Institutions Holding BAX

# of Institutions

1,007

Shares Held

450M

Call Options Held

2.79M

Put Options Held

2.44M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.9B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.

Account

Cullen/Frost Bankers, Inc. Baxter International Inc Transaction History